ArticleBrazilian journal of otorhinolaryngology2026
Causal associations between plasma miRNAS and allergic rhinitis: A two-sample Mendelian randomization and functional enrichment study.
Article in Brazilian journal of otorhinolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAllergic rhinitis is a prevalent inflammatory disorder driven by complex immune dysregulation. While circulating miRNAs are known regulators of gene expression, their specific causal roles in the pathogenesis of allergic rhinitis remain largely undefined.
methodsWe performed a comprehensive two-sample Mendelian randomization analysis to investigate the causal effect of plasma miRNAs on allergic rhinitis. Genetic instruments were obtained from large-scale miRNA eQTL datasets. Causal estimates were primarily evaluated using allergic rhinitis summary statistics from the GWAS catalog dataset and robustly validated in the independent FinnGen cohort (15,569 cases and 474,650 controls). Sensitivity analyses, including Bayesian colocalization and reverse Mendelian randomization, were conducted to ensure validity. Downstream mechanisms were explored via enrichment analyses of predicted targets.
resultsWe identified significant causal associations for multiple miRNAs. Notably, miR-130a-3p was consistently validated as a risk factor for allergic rhinitis across cohorts, whereas miR-1908-5p, miR-146a-3p, and miR-6891-3p exhibited protective effects. Colocalization analysis offered suggestive evidence of shared genetic variants for miR-148a-3p and the miR-181 family, with no evidence of reverse causality. Functional enrichment analysis revealed that target genes of these miRNAs are significantly involved in Wnt signaling, MAPK signaling, focal adhesion, and neurogenesis, implicating them in epithelial barrier regulation and neurogenic inflammation.
conclusionsThis study provides genetic support for potential causal associations between circulating miRNAs and allergic rhinitis risk, prioritizing miR-130a-3p and miR-1908-5p as candidate regulators that warrant further functional validation. LEVEL OF EVIDENCE: Level 5. Mendelian Randomized (MR) studies are second only to randomized controlled trials in terms of the level of evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.